PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma
European Journal of Nuclear Medicine & Molecular Imaging, 05/10/2012
Hanscheid H et al. – PET with 68Ga–labelled somatostatin analogues allows the pretherapeutic assessment of tumour radionuclide uptake in peptide receptor radionuclide therapy (PRRT) of meningioma and an estimate of the achievable dose.



